+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Niacinamide Market by Form, Production, Grade, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5613096
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Niacinamide Market grew from USD 715.77 million in 2023 to USD 745.60 million in 2024. It is expected to continue growing at a CAGR of 4.65%, reaching USD 984.11 million by 2030.

Niacinamide, also known as vitamin B3, has seen increasing adoption across various sectors, primarily in the cosmetic and healthcare industries. Its importance lies in its multi-functional properties, including anti-inflammatory, antioxidant, and skin-brightening benefits, which make it a potent ingredient in skincare formulations. It is also used in nutritional supplements due to its role in cellular metabolism. The growing consumer awareness of skincare and wellness, coupled with the inclination towards products with dual benefits, fuels the demand for niacinamide. The rising trend of self-care and wellness amongst millennials and Gen Z further catalyzes this growth. Key market influencing factors include the increased preference for natural and organic products, advancements in delivery systems for enhanced skin penetration, and continuous research into novel applications in skincare and pharmaceuticals. Geographic market expansion is observed, particularly in regions like Asia-Pacific, where traditional herbal medicine is integrating modern ingredients like niacinamide. However, the market faces challenges such as regulatory hurdles, potential irritation for sensitive skin, and price sensitivity in emerging economies. Continual research and innovation can lead to the development of niacinamide derivatives or formulations with better bioavailability, creating opportunities for niche product development. Additionally, businesses can leverage personalized skincare approaches, employing technology-driven customization to meet specific consumer needs. In terms of innovation, companies could focus on combining niacinamide with other active ingredients to enhance its efficacy or explore sustainable sourcing methods to appeal to environmentally-conscious consumers. Despite its potential, the market’s growth can be limited by intense competition and the familiarity of consumers with traditional skincare alternatives. Overall, the niacinamide market’s evolving nature prompts a dynamic strategy involving ongoing research, consumer education, and a focus on sustainability to maintain competitive advantage and capture emerging opportunities.

Understanding Market Dynamics in the Niacinamide Market

The Niacinamide Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Consumer demand for niacinamide-containing foods or supplements for diabetes, osteoarthritis, and hyperphosphatemia
    • Increasing demand for skin care products containing niacinamide
    • Growing use of niacinamide for animal feed fortification
  • Market Restraints
    • Limited availability and volatility of the prices of ingredients
  • Market Opportunities
    • Extensive R&D activities to develop niacinamide therapies for the treatment of cancer
    • Growing preference for Over-the-counter (OTC) cosmeceuticals
  • Market Challenges
    • Adverse side effects and allergic reactions associated with the long-term use of niacinamide

Exploring Porter’s Five Forces for the Niacinamide Market

Porter’s Five Forces framework further strengthens the insights of the Niacinamide Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Niacinamide Market

External macro-environmental factors deeply influence the performance of the Niacinamide Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Niacinamide Market

The Niacinamide Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Niacinamide Market

The Niacinamide Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Niacinamide Market

The Niacinamide Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Niacinamide Market, highlighting leading vendors and their innovative profiles. These include AIE Pharmaceuticals, Inc., Bio-Tech Pharmacal, Inc., Evonik Industries AG, Fagron Inc., Foodchem International Corporation, Gemini Pharmaceuticals, Glanbia PLC, Koninklijke DSM N.V., Lasons India Pvt Ltd., Lonza Group AG, Merck KGaA, NutraScience Labs, Spectrum Chemical Mfg. Corporation, Vertellus LLC, Western Drugs Ltd., and Yuki Gosei Kogyo Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Niacinamide Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Form
    • Granular
    • Liquid
    • Powder
  • Production
    • Natural
    • Synthetic
  • Grade
    • Feed Grade
    • Pharmaceutical Grade
  • Application
    • Animal Nutrition
    • Cosmeceuticals
    • Human Nutrition
    • Pharmaceuticals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Consumer demand for niacinamide-containing foods or supplements for diabetes, osteoarthritis, and hyperphosphatemia
5.1.1.2. Increasing demand for skin care products containing niacinamide
5.1.1.3. Growing use of niacinamide for animal feed fortification
5.1.2. Restraints
5.1.2.1. Limited availability and volatility of the prices of ingredients
5.1.3. Opportunities
5.1.3.1. Extensive R&D activities to develop niacinamide therapies for the treatment of cancer
5.1.3.2. Growing preference for Over-the-counter (OTC) cosmeceuticals
5.1.4. Challenges
5.1.4.1. Adverse side effects and allergic reactions associated with the long-term use of niacinamide
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Niacinamide Market, by Form
6.1. Introduction
6.2. Granular
6.3. Liquid
6.4. Powder
7. Niacinamide Market, by Production
7.1. Introduction
7.2. Natural
7.3. Synthetic
8. Niacinamide Market, by Grade
8.1. Introduction
8.2. Feed Grade
8.3. Pharmaceutical Grade
9. Niacinamide Market, by Application
9.1. Introduction
9.2. Animal Nutrition
9.3. Cosmeceuticals
9.4. Human Nutrition
9.5. Pharmaceuticals
10. Americas Niacinamide Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Niacinamide Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Niacinamide Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. NIACINAMIDE MARKET RESEARCH PROCESS
FIGURE 2. NIACINAMIDE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL NIACINAMIDE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL NIACINAMIDE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2023 VS 2030 (%)
FIGURE 7. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL NIACINAMIDE MARKET SIZE, BY GRADE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL NIACINAMIDE MARKET SIZE, BY GRADE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES NIACINAMIDE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES NIACINAMIDE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. NIACINAMIDE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. NIACINAMIDE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. NIACINAMIDE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL NIACINAMIDE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NIACINAMIDE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. NIACINAMIDE MARKET DYNAMICS
TABLE 7. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NIACINAMIDE MARKET SIZE, BY GRANULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NIACINAMIDE MARKET SIZE, BY FEED GRADE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICAL GRADE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMECEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NIACINAMIDE MARKET SIZE, BY HUMAN NUTRITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. CANADA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 36. CANADA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 37. CANADA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 38. CANADA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. MEXICO NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 40. MEXICO NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 41. MEXICO NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 42. MEXICO NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES NIACINAMIDE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. CHINA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 58. CHINA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 59. CHINA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 60. CHINA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. INDIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 62. INDIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 63. INDIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 64. INDIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. JAPAN NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 70. JAPAN NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 71. JAPAN NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 72. JAPAN NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. THAILAND NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 94. THAILAND NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 95. THAILAND NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 96. THAILAND NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 106. DENMARK NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 107. DENMARK NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 108. DENMARK NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 109. DENMARK NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. EGYPT NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 111. EGYPT NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 112. EGYPT NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 113. EGYPT NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. FINLAND NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 115. FINLAND NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 116. FINLAND NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 117. FINLAND NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. FRANCE NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 119. FRANCE NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 120. FRANCE NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 121. FRANCE NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. GERMANY NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 123. GERMANY NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 124. GERMANY NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 125. GERMANY NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. ITALY NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 131. ITALY NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 132. ITALY NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 133. ITALY NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. NORWAY NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 143. NORWAY NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 144. NORWAY NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 145. NORWAY NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. POLAND NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 147. POLAND NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 148. POLAND NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 149. POLAND NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. QATAR NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 151. QATAR NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 152. QATAR NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 153. QATAR NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SPAIN NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 167. SPAIN NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 168. SPAIN NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 169. SPAIN NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. TURKEY NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 179. TURKEY NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 180. TURKEY NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 181. TURKEY NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. NIACINAMIDE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 191. NIACINAMIDE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Niacinamide Market, which are profiled in this report, include:
  • AIE Pharmaceuticals, Inc.
  • Bio-Tech Pharmacal, Inc.
  • Evonik Industries AG
  • Fagron Inc.
  • Foodchem International Corporation
  • Gemini Pharmaceuticals
  • Glanbia PLC
  • Koninklijke DSM N.V.
  • Lasons India Pvt Ltd.
  • Lonza Group AG
  • Merck KGaA
  • NutraScience Labs
  • Spectrum Chemical Mfg. Corporation
  • Vertellus LLC
  • Western Drugs Ltd.
  • Yuki Gosei Kogyo Co., Ltd.

Methodology

Loading
LOADING...

Table Information